Karyopharm Therapeutics Inc (KPTI) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Karyopharm Therapeutics Inc   (NASDAQ: KPTI)
 

Karyopharm Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Karyopharm Therapeutics Inc inventory turnover ratio, the Karyopharm Therapeutics Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.44 in the first quarter 2026, KPTI's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Karyopharm Therapeutics Inc in Mar 31 2026 quarter, has decreased to 253 days, compare to 272 days, in the Dec 31 2025 quarter.

Within Healthcare sector 264 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 844 in the fourth quarter 2025, to 1496.

KPTI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Karyopharm Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KPTI Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth -24.53 % -14.79 % -15.11 % 43.61 % 72.23 %
Y / Y Cost of Sales Growth 3.38 % 11.5 % 62.54 % -28.26 % -31.92 %
Inventory Turnover Ratio (TTM) 1.44 1.34 1.26 1.04 1.22
KPTI's Total Ranking # 1496 # 844 # 1117 # 1524 # 1251
Average inventory processing period 253 272 291 351 299
Seq. Inventory Growth -10.87 % 1.82 % -20.55 % 4.68 % 0.63 %
Seq. Cost of Sales Growth -9.37 % -29.77 % 101.05 % -19.22 % -2.25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 72
Healthcare Sector # 265
Overall Market # 1496

Inventory Turnover Ratio Statistics
High Average Low
2.64 1.41 0.24
(Jun 30 2020)   (Jun 30 2022)



KPTI Company Profile >> Back to KPTI Efficiency Comparisons >> Compare KPTI Inventory Turnover Ratio to its Competitors

Financial Statements
Karyopharm Therapeutics Inc 's Inventories $ 4 Millions Visit KPTI's Balance sheet
Karyopharm Therapeutics Inc 's Cost of Revenues TTM $ 6 Millions Visit KPTI's Income Statement
What are KPTI's Sales? Visit KPTI's Sales by Segment

Other Inventory Turnover Ratios
Karyopharm Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KPTI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KPTI's Competitors
Inventory Turnover Ratio for KPTI's Suppliers
Inventory Turnover Ratio for KPTI's Customers

You may also want to know
KPTI's Sales Growth Rates KPTI's Pe Price to earnings ratio KPTI's Receivables Turnover Ratio KPTI's Stock Quote
KPTI's Net Income Growth Rates KPTI's Ps Price to Sales ratio KPTI's Sales per Employee KPTI's Asset Turnover Ratio
KPTI's Net Margin KPTI's Pb Price to Book ratio KPTI's Financial Strength Ratios KPTI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions
Cryoport inc   4.23 $ 96.609  Millions$ 23  Millions
Teva Pharmaceutical Industries Limited  4.22 $ 8,317.000  Millions$ 1,971  Millions
Incyte Corporation  4.21 $ 403.465  Millions$ 96  Millions
Electromed Inc   4.16 $ 14.195  Millions$ 3  Millions
Vericel Corporation  4.15 $ 73.494  Millions$ 18  Millions
Sharps Technology Inc   4.12 $ 3.585  Millions$ 1  Millions
Coherus Oncology inc   4.11 $ 14.975  Millions$ 4  Millions
Novocure Limited  4.08 $ 167.287  Millions$ 41  Millions
Lifeward ltd   4.08 $ 13.275  Millions$ 3  Millions
Ge Healthcare Technologies Inc   4.04 $ 9,262.000  Millions$ 2,294  Millions
Koru Medical Systems Inc   3.99 $ 16.468  Millions$ 4  Millions
3m Company  3.94 $ 15,087.000  Millions$ 3,830  Millions
Iridex Corp  3.92 $ 32.247  Millions$ 8  Millions
Myomo Inc   3.88 $ 14.000  Millions$ 4  Millions
Escalon Medical Corp   3.79 $ 6.698  Millions$ 2  Millions
Evolus Inc   3.71 $ 103.000  Millions$ 28  Millions
Abbvie Inc   3.70 $ 18,420.000  Millions$ 4,975  Millions
Alpha Teknova Inc   3.69 $ 26.248  Millions$ 7  Millions
Biocryst Pharmaceuticals Inc   3.67 $ 19.884  Millions$ 5  Millions
Neuraxis Inc   3.61 $ 0.665  Millions$ 0  Millions
Mirum Pharmaceuticals Inc   3.50 $ 85.221  Millions$ 24  Millions
Elite Pharmaceuticals Inc   3.43 $ 71.976  Millions$ 21  Millions
Tandem Diabetes Care Inc   3.42 $ 457.823  Millions$ 134  Millions
Exelixis Inc   3.41 $ 84.478  Millions$ 25  Millions
Baxter International Inc   3.37 $ 7,911.000  Millions$ 2,348  Millions

Date modified: 2026-08-30T14:45:59+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.